Update on the diagnosis and treatment of cholangiocarcinoma
B Doherty, VE Nambudiri, WC Palmer - Current gastroenterology reports, 2017 - Springer
Abstract Purpose of Review Cholangiocarcinoma is a rare biliary adenocarcinoma
associated with poor outcomes. Cholangiocarcinoma is subdivided into extrahepatic and …
associated with poor outcomes. Cholangiocarcinoma is subdivided into extrahepatic and …
Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma
LM Boehm, TT Jayakrishnan, JT Miura… - Journal of surgical …, 2015 - Wiley Online Library
Background Hepatic artery based therapies (HAT) are offered for patients with unresectable
intrahepatic cholangiocarcinoma (ICC). We aimed to evaluate the comparative effectiveness …
intrahepatic cholangiocarcinoma (ICC). We aimed to evaluate the comparative effectiveness …
Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis
Background Many patients with intrahepatic cholangiocarcinoma (ICC) present with
advanced and inoperable disease. Data on the safety and efficacy of intra-arterial therapy …
advanced and inoperable disease. Data on the safety and efficacy of intra-arterial therapy …
Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and …
JB Kuhlmann, W Euringer… - European journal of …, 2012 - journals.lww.com
Background Unresectable cholangiocarcinoma (CCC) has a poor prognosis. Patients with
intrahepatic CCC have a very limited benefit from systemic chemotherapy (ChT). The aim of …
intrahepatic CCC have a very limited benefit from systemic chemotherapy (ChT). The aim of …
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral …
G Brandi, M Venturi, MA Pantaleo, G Ercolani… - Digestive and Liver …, 2016 - Elsevier
In the oncology landscape, cholangiocarcinoma is a challenging disease in terms of both
diagnosis and treatment. Besides anamnesis and clinical examination, a definitive diagnosis …
diagnosis and treatment. Besides anamnesis and clinical examination, a definitive diagnosis …
Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results
C Aliberti, G Benea, M Tilli, G Fiorentini - Cardiovascular and interventional …, 2008 - Springer
The purpose of this study was to evaluate the safety and efficacy of TACE with microspheres
preloaded with doxorubicin in unresectable intrahepatic cholangiocarcinoma (UCH). Twenty …
preloaded with doxorubicin in unresectable intrahepatic cholangiocarcinoma (UCH). Twenty …
Role of 18F-FDG PET/CT imaging in intrahepatic cholangiocarcinoma
L Jiang, H Tan, CM Panje, H Yu, Y Xiu… - Clinical nuclear …, 2016 - journals.lww.com
Purpose Although intrahepatic cholangiocarcinoma (ICC) is the second most common
primary hepatic malignancy after hepatocellular carcinoma, there are limited data available …
primary hepatic malignancy after hepatocellular carcinoma, there are limited data available …
[HTML][HTML] Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma
DH Jung, MS Kim, CK Cho, HJ Yoo… - Radiation oncology …, 2014 - ncbi.nlm.nih.gov
Purpose To report the results of stereotactic body radiotherapy (SBRT) for unresectable
primary or recurrent cholangiocarcinoma. Materials and Methods From January 2005 …
primary or recurrent cholangiocarcinoma. Materials and Methods From January 2005 …
Management of perihilar cholangiocarcinoma in the era of multimodal therapy
V Valero III, D Cosgrove, JM Herman… - Expert review of …, 2012 - Taylor & Francis
Perihilar cholangiocarcinoma (CCA) is the second most common primary malignant tumor of
the liver. In the USA, there are approximately 3000 cases of CCA diagnosed annually, with …
the liver. In the USA, there are approximately 3000 cases of CCA diagnosed annually, with …
Stereotactic radiofrequency ablation of unresectable intrahepatic cholangiocarcinomas: a retrospective study
M Haidu, G Dobrozemsky, P Schullian… - Cardiovascular and …, 2012 - Springer
Purpose To evaluate treatment effects, complications, and outcome of percutaneous
stereotactic radiofrequency ablation (SRFA) of intrahepatic cholangiocarcinoma (ICC) …
stereotactic radiofrequency ablation (SRFA) of intrahepatic cholangiocarcinoma (ICC) …